TIME Health Care

Pharma Company Behind Meningitis Outbreak to Shell Out $100 Million

A $100 million settlement was reached on Tuesday, between New England attorneys and a pharmaceutical company that produced tainted drugs responsible for the deadly meningitis outbreak in 2012, to provide compensation to insurers and victims

Attorneys in New England reached a proposed $100 million settlement on Tuesday with the owners of the pharmaceutical operation that produced tainted drugs responsible for the 2012 nationwide meningitis outbreak that killed 64 people.

The $100 million deal will provide compensation to insurers and victims of the outbreak in accordance with a Chapter 11 plan filed by the owners of New England Compounding Pharmacy Inc., according to Bloomberg.

The outbreak, which infected more than 700 people, was largely blamed on a steroid administered by spinal injection that was produced by the company.

A judge must still approve the settlement along with a system that will distribute the funds to victims awaiting compensation.

Tap to read full story

Your browser is out of date. Please update your browser at http://update.microsoft.com


Dear TIME Reader,

As a regular visitor to TIME.com, we are sure you enjoy all the great journalism created by our editors and reporters. Great journalism has great value, and it costs money to make it. One of the main ways we cover our costs is through advertising.

The use of software that blocks ads limits our ability to provide you with the journalism you enjoy. Consider turning your Ad Blocker off so that we can continue to provide the world class journalism you have become accustomed to.

The TIME Team